ARCHIVES

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

ASBMT Installs New Officers

March 14, 2003

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

December 17, 2010

Rall Supports Animal Tests; Carcinogenesis Reports Summarized

May 13, 1977

European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results

June 5, 1987

Outside NIH, Applied Research Underfunded; Strong Federal Role Needed, Chabner Says

May 12, 1995

Court Orders NIH To Retract Electronic Annotations On Fisher Publications

March 24, 1995